249 related articles for article (PubMed ID: 28038455)
21. Upregulation of
Wu L; Ling ZH; Wang H; Wang XY; Gui J
Cancer Biother Radiopharm; 2019 Dec; 34(10):642-649. PubMed ID: 31549859
[No Abstract] [Full Text] [Related]
22. Nectin cell adhesion molecule-4 (NECTIN-4): A potential target for cancer therapy.
Chatterjee S; Sinha S; Kundu CN
Eur J Pharmacol; 2021 Nov; 911():174516. PubMed ID: 34547246
[TBL] [Abstract][Full Text] [Related]
23. The expression of the Nectin complex in human breast cancer and the role of Nectin-3 in the control of tight junctions during metastasis.
Martin TA; Lane J; Harrison GM; Jiang WG
PLoS One; 2013; 8(12):e82696. PubMed ID: 24386110
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of astrocyte-elevated gene-1 is associated with ovarian cancer development and progression.
Zhou B; Yang J; Shu B; Liu K; Xue L; Su N; Liu J; Xi T
Mol Med Rep; 2015 Apr; 11(4):2981-90. PubMed ID: 25483832
[TBL] [Abstract][Full Text] [Related]
25. Nectin-4 is a breast cancer stem cell marker that induces WNT/β-catenin signaling via Pi3k/Akt axis.
Siddharth S; Goutam K; Das S; Nayak A; Nayak D; Sethy C; Wyatt MD; Kundu CN
Int J Biochem Cell Biol; 2017 Aug; 89():85-94. PubMed ID: 28600142
[TBL] [Abstract][Full Text] [Related]
26. Microparticles from ovarian carcinomas are shed into ascites and promote cell migration.
Press JZ; Reyes M; Pitteri SJ; Pennil C; Garcia R; Goff BA; Hanash SM; Swisher EM
Int J Gynecol Cancer; 2012 May; 22(4):546-52. PubMed ID: 22315094
[TBL] [Abstract][Full Text] [Related]
27. Cdc42 and Rac small G proteins activated by trans-interactions of nectins are involved in activation of c-Jun N-terminal kinase, but not in association of nectins and cadherin to form adherens junctions, in fibroblasts.
Honda T; Shimizu K; Kawakatsu T; Fukuhara A; Irie K; Nakamura T; Matsuda M; Takai Y
Genes Cells; 2003 May; 8(5):481-91. PubMed ID: 12694536
[TBL] [Abstract][Full Text] [Related]
28. Heterogeneous Cadherin Expression and Multicellular Aggregate Dynamics in Ovarian Cancer Dissemination.
Klymenko Y; Johnson J; Bos B; Lombard R; Campbell L; Loughran E; Stack MS
Neoplasia; 2017 Jul; 19(7):549-563. PubMed ID: 28601643
[TBL] [Abstract][Full Text] [Related]
29. Nectin-4 promotes gastric cancer progression via the PI3K/AKT signaling pathway.
Zhang Y; Chen P; Yin W; Ji Y; Shen Q; Ni Q
Hum Pathol; 2018 Feb; 72():107-116. PubMed ID: 29208564
[TBL] [Abstract][Full Text] [Related]
30. Silencing of twist expression by RNA interference suppresses epithelial-mesenchymal transition, invasion, and metastasis of ovarian cancer.
Wang WS; Yang XS; Xia M; Jiang HY; Hou JQ
Asian Pac J Cancer Prev; 2012; 13(9):4435-9. PubMed ID: 23167357
[TBL] [Abstract][Full Text] [Related]
31. Malignant ascites enhances migratory and invasive properties of ovarian cancer cells with membrane bound IL-6R in vitro.
Kim S; Gwak H; Kim HS; Kim B; Dhanasekaran DN; Song YS
Oncotarget; 2016 Dec; 7(50):83148-83159. PubMed ID: 27825119
[TBL] [Abstract][Full Text] [Related]
32. The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma.
Kinose Y; Sawada K; Nakamura K; Sawada I; Toda A; Nakatsuka E; Hashimoto K; Mabuchi S; Takahashi K; Kurachi H; Lengyel E; Kimura T
Oncotarget; 2015 May; 6(13):11342-56. PubMed ID: 25839163
[TBL] [Abstract][Full Text] [Related]
33. SMYD3 promotes implant metastasis of ovarian cancer via H3K4 trimethylation of integrin promoters.
Lyu T; Jiang Y; Jia N; Che X; Li Q; Yu Y; Hua K; Bast RC; Feng W
Int J Cancer; 2020 Mar; 146(6):1553-1567. PubMed ID: 31503345
[TBL] [Abstract][Full Text] [Related]
34. Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion.
Henry C; Llamosas E; Knipprath-Meszaros A; Schoetzau A; Obermann E; Fuenfschilling M; Caduff R; Fink D; Hacker N; Ward R; Heinzelmann-Schwarz V; Ford C
Oncotarget; 2015 Nov; 6(37):40310-26. PubMed ID: 26515598
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of glypican-3 expression increases migration, invasion, and tumorigenicity of human ovarian cancer cells.
Liu Y; Zheng D; Liu M; Bai J; Zhou X; Gong B; Lü J; Zhang Y; Huang H; Luo W; Huang G
Tumour Biol; 2015 Sep; 36(10):7997-8006. PubMed ID: 25967456
[TBL] [Abstract][Full Text] [Related]
36. [Expression and significance of MAPK/ERK in the specimens and cells of epithelial ovarian cancer].
Jiang XL; Gao JC; Jiang L; Zhang PX; Kang TJ; Sun Q; Qi WJ; Zhang QP; Guan HW; Shi H
Zhonghua Fu Chan Ke Za Zhi; 2019 Aug; 54(8):541-547. PubMed ID: 31461811
[No Abstract] [Full Text] [Related]
37. Functional characterization of a panel of high-grade serous ovarian cancer cell lines as representative experimental models of the disease.
Haley J; Tomar S; Pulliam N; Xiong S; Perkins SM; Karpf AR; Mitra S; Nephew KP; Mitra AK
Oncotarget; 2016 May; 7(22):32810-20. PubMed ID: 27147568
[TBL] [Abstract][Full Text] [Related]
38. TROP-1/Ep-CAM and CD24 are potential candidates for ovarian cancer therapy.
Wang G; Zhang Z; Ren Y
Int J Clin Exp Pathol; 2015; 8(5):4705-14. PubMed ID: 26191160
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Potential of Nectin Expressions in Colorectal Cancer: An Exploratory Study.
Kobecki J; Gajdzis P; Mazur G; Chabowski M
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958883
[TBL] [Abstract][Full Text] [Related]
40. [Nectin and nectin-like molecules as markers, actors and targets in cancer].
Fournier G; Garrido-Urbani S; Reymond N; Lopez M
Med Sci (Paris); 2010 Mar; 26(3):273-9. PubMed ID: 20346277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
